Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

NCT05364021 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Developmental and Epileptic Encephalopathy
Dravet Syndrome
Lennox Gastaut Syndrome

Interventions

DRUG: LP352
DRUG: Placebo

Sponsor

Longboard Pharmaceuticals